- Most of our events take place in the McKusick Conference Room at Mission Hall, also known as the Global Health & Clinical Sciences Building on Mission Bay Campus, unless otherwise noted. [Directions to CAPS]
- RSVP to Rochelle Blanco if you would like to attend. You will need to check in at the security desk upon arrival. Mention “Town Hall” at the security desk to expedite entry approval.
Tuesday, March 24th, 2015
CAPS Town Hall Presents Dr. Elvin Geng (12:00 – 1:00 pm)
Dr. Elvin Geng is trained in infectious diseases (MD, Columbia 2002) and epidemiology (MPH, Columbia 2002). His research seeks to apply perspectives from implementation and dissemination sciences to understand the effectiveness of global antiretroviral treatment (ART) programs for HIV-infected patients. Currently, the Global Fund, US President’s Emergency Fund for AIDS Relief (PEPFAR) and national governments have invested billions of dollars for AIDS programs and started five million persons on ART in resource limited settings. Yet the best strategies for engagement in care and treatment with life-long, complicated and potentially toxic medications include many unanswered questions. For patients who present to care, failure to initiate ART is under appreciated and a major barrier that is poorly understood. Once on ART, early mortality – likely to due to ascertained opportunistic infections – is high and the causes incompletely understood. Among patients who stabilize on ART, loss to follow-up is ubiquitous in African ART programs. To address these problems Dr. Geng is involved in a number of studies including (1) assembly of a cohort of HIV-infected patients in southwestern Uganda as part of an NIH funded consortium in East Africa; (2) a nested case control study to identify causes of early mortality in Uganda; (3) extending novel methods into the cohort setting to study engagement in care and (4) and using causal methods to understand longitudinal treatment effects in data collected in these settings.
Dr. Geng hopes to bring clinical contextual knowledge to bear on analysis of data from “real world” settings to improve the effectiveness of global ART implementation, yielding generalizable lessons for science of implementation in health care that may be of use in other settings and other disease conditions.